Spyrocon Dosage/Direction for Use

Short-term treatment: Dermatomycosis : 100 mg once daily for 15 days.
Pityriasis versicolor: 200 mg once daily for 7 days.
Vulvovaginal candidiasis: 200 mg twice daily for only 1 day; or 200 mg once daily for 3 days.
Highly keratinized regions as in plantar tinea pedis and palmar tinea manus require additional treatment of 100 mg daily for 15 days.
Oral candidiasis: 100 mg once daily for 15 days. In some immunocompromised patients, e.g. neutropenic, AIDS or organ transplant patients, the oral bioavailabillity of Itraconazole may be decreased. Therefore, the dose may need doubling.
Fungal keratitis: 200 mg once daily for 21 days.
Elimination of Itraconazole from skin tissue is slower than from plasma. Optimal clinical and mycological effects are thus reached 2-4 weeks after the cessation of these treatment courses.
Long-term treatment: Aspergillosis: 200 mg once daily for 2-5 months.
Candidiasis: 100-200 mg once daily for 3-7 weeks.
Increase dose to 200 mg twice daily in case of invasive or disseminated disease.
Non-meningeal cryptococcosis: 200 mg once daily for 2 months-1 year.
Cryptococcal meningitis: 200 mg twice daily for 2 months-1 year.
Maintenance therapy (meningeal cases) 200 mg once daily.
Blastomycosis: 100 mg once daily or 200 mg twice daily for 6 months.
Histoplasmosis: 200 mg once daily to 200 mg twice daily for 8 months. Paracoccidioidomycosis: 100 mg once daily for 6 months.
Sporotrichosis: 100 mg once daily for 3 months.